• 1
    Oesterling JE. Benign prostatic hyperplasia: a review of its histogenesis and natural history. Prostate Suppl 1996; 6: 6773.
  • 2
    Richard F, Lukacs B, Jardin A et al. Results of an epidemiologic surgery carried out with men 50–80 years of age to study urinary disorders, quality of life and sexual function. Prog Urol 2001; 11: 25063.
  • 3
    Clifford GM, Logie J, Farmer RD. How do symptoms indicative of BPH progress in real life practice? The UK experience Eur Urol 2000; 38: 4853.
  • 4
    Verhamme KMC, Dieleman JP, Bleumink GS, Van derLei J, Sturkenboom MCJM. TRIUMPH Pan European Expert Panel Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperpklasia in primary care – the TRIUMPH project. Eur Urol 2002; 42: 3238.
  • 5
    Schulman CC. The aging male: a challenge for urologists. Curr Opin Urol 2000; 10: 33742.
  • 6
    Trueman P, Hood SC, Navak US, Mrazek MF. Prevalence of lower urinary tract symptoms and self-reported diagnosed “benign prostatic hyperplasia”, and their effect on quality of life in a community-based survey of men in the UK. BJU Int 1999; 83: 4105.
  • 7
    Girman CJ, Jacobsen SJ, Tsukamoto T et al. Health-related quality of life associated with lower urinary tract symptoms in four countries. Urology 1998; 51: 42836.
  • 8
    Van Exel NJ, Koopmanschap MA, McDonnell J et al. Medical consumption and costs during a one-year follow-up of patients with LUTS suggestive of BPH in six European countries: report of the TRIUMPH study. Eur Urol 2006; 49: 92102.
  • 9
    Fourcade RO, Thèret N, Taieb C; on behalf of the BPH USAGE Study Group. Profile and management of patients treated for the first time for lower urinary tract symptoms/bening prostatic hyperplasia in four European countries. BJU Intern 2008; 101: 11118
  • 10
    Carballido J, Fourcade R, Pagliarulo A et al. Can simple tests performed in the primary care setting provide accurate and efficient diagnosis of benign prostatic hyperplasia? Rationale and design of the diagnosis improvement in Primary Care Trial. Int J Clin Pract 2009; 63: 11927.
  • 11
    Hutchinson A, Farmer R, Chapple C et al. Characteristics of patients presenting with LUTS/BPH in six European countries. Eur Urol 2006; 50: 55562.
  • 12
    Cornu JN, Cussenot O, Haab F, Lukacs B. A widespread population study of actual medical management of lower urinary tract symptoms related to benign prostatic hyperplasia across Europe and beyond official clinical guidelines. Eur Urol 2010; 58: 4506.
  • 13
    Barry MJ, Fowler FJ, O’Leary MP et al. The Measurement Committee of the American Urological Association. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol 1992; 148: 154957.